Publication Name	World Journal of Stem Cells
Manuscript ID	99331
Country	Portugal

Received	2024-07-19 17:42
Peer-Review Started	2024-07-19 17:42
To Make the First Decision
Return for Revision	2024-11-11 08:34
Revised	2024-11-21 10:56
Second Decision	2024-12-17 02:46
Accepted by Journal Editor-in-Chief	2024-12-20 00:38
Accepted by Executive Editor-in-Chief	2025-01-14 06:48
Articles in Press	2025-01-14 06:48
Publication Fee Transferred
Edit the Manuscript by Language Editor	2025-01-19 10:15
Typeset the Manuscript	2025-02-05 09:26
Publish the Manuscript Online	2025-02-24 05:39

ISSN	1948-0210 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Medicine, Research & Experimental
Manuscript Type	Minireviews
Article Title	Induced pluripotent stem cells-derived mesenchymal stem cells for modelling and treating non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: Challenges and opportunities
Manuscript Source	Invited Manuscript
All Author List	Bárbara Silva and José Bragança
Funding Agency and Grant Number	Funding Agency Grant Number American Heart Association Award 24IVPHA1288417 FCT Fellowships 2022.13253.BDANA
Corresponding Author	José Bragança, Associate Professor, PhD, Faculty of Medicine and Biomedical Sciences, Algarve Biomedical Center-Research Institute, University of Algarve, Campus of Gambelas, Building 8, Room 2.22, Faro 8005-139, Portugal. jebraganca@ualg.pt
Key Words	Non-alcoholic fatty liver disease; Non-alcoholic steatohepatitis; Mesenchymal stem cells; Induced pluripotent stem cells; In vitro liver models
Core Tip	Induced pluripotent stem cells (iPSCs) show promise for modelling and treating non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. iPSCs can generate various cell types, including cells for therapy or disease modelling. Challenges remain, but iPSCs offer potential for drug discovery and personalized medicine approaches for non-alcoholic fatty liver disease/non-alcoholic steatohepatitis.
Publish Date	2025-02-24 05:39
Citation	<p>Silva B, Bragança J. Induced pluripotent stem cells-derived mesenchymal stem cells for modelling and treating non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: Challenges and opportunities. <i>World J Stem Cells</i> 2025; 17(2): 99331</p>
URL	https://www.wjgnet.com/1948-0210/full/v17/i2/99331.htm
DOI	https://dx.doi.org/10.4252/wjsc.v17.i2.99331

Full Article (PDF)	WJSC-17-99331-with-cover.pdf
Manuscript File	99331_Auto_Edited_015241.docx
Answering Reviewers	99331-answering-reviewers.pdf
Audio Core Tip	99331-audio.mp3
Conflict-of-Interest Disclosure Form	99331-conflict-of-interest-statement.pdf
Copyright License Agreement	99331-copyright-assignment.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s)	99331-foundation-statement.pdf
Non-Native Speakers of English Editing Certificate	99331-non-native-speakers.pdf
Peer-review Report	99331-peer-reviews.pdf
Journal Editor-in-Chief Review Report	99331-journal-editor-in-chief.pdf
Scientific Misconduct Check	99331-scientific-misconduct-check.png
Scientific Editor Work List	99331-scientific-editor-work-list.pdf
CrossCheck Report	99331-crosscheck-report.pdf